{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:03:49Z","timestamp":1791180229970,"version":"4.1.0"},"reference-count":0,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2002,1,5]],"date-time":"2002-01-05T00:00:00Z","timestamp":1010188800000},"content-version":"vor","delay-in-days":980,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Scand J Immunol"],"published-print":{"date-parts":[[1999,5]]},"abstract":"<jats:p>Sj\u00f6gren's syndrome (SS) is a chronic autoimmune disease of exocrine glands. There is increasing evidence that interferon\u2010\u03b3 (IFN\u2010\u03b3) plays a role in the pathogenesis of SS. It has also been suggested that other type 1 cytokines, as well as interleukin\u20106 (IL\u20106), IL\u201010 and transforming growth factor\u2010\u03b2, are important in the induction and\/or maintenance of SS. The aim of this study was to investigate the type 1\/type 2 cytokine pattern in peripheral blood of primary SS patients. The enzyme\u2010linked immunospot (ELISPOT) assay was performed to quantify the number of mononuclear cells (MNC) secreting IFN\u2010\u03b3, IL\u20106 and IL\u201010 in peripheral blood samples from 33 patients with primary SS and 12 healthy controls. The mean number of cells secreting IFN\u2010\u03b3 was 9\/10<jats:sup>5<\/jats:sup> MNC in the SS patient group, and 4\/10<jats:sup>5<\/jats:sup> MNC in the control group (<jats:italic>P<\/jats:italic>\u2003=\u20030.73). Fifteen of the SS patients had anti\u2010Ro 52\u2003kDa antibodies in serum. In this patient group the mean number of cells secreting IFN\u2010\u03b3 was 4\/10<jats:sup>5<\/jats:sup> MNC, while in the patient group without such antibodies the mean number of cells secreting IFN\u2010\u03b3 was 14\/10<jats:sup>5<\/jats:sup> MNC (<jats:italic>P<\/jats:italic>\u2003=\u20030.04). The mean number of cells secreting IL\u20106 was 12\u2003000\/10<jats:sup>5<\/jats:sup> MNC in the SS patient group, and 5000\/10<jats:sup>5<\/jats:sup> MNC in the control group (<jats:italic>P<\/jats:italic>\u2003=\u20030.01). The mean number of cells secreting IL\u201010 was 270\/10<jats:sup>5<\/jats:sup> MNC in the SS patient group, and 180\/10<jats:sup>5<\/jats:sup> MNC in the control group (<jats:italic>P<\/jats:italic>\u2003=\u20030.04). The SS patients had a significantly higher number of cells secreting IL\u20106 and IL\u201010 in peripheral blood than the healthy controls, which may facilitate B\u2010cell activation and production of autoantibodies.<\/jats:p>","DOI":"10.1046\/j.1365-3083.1999.00533.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T20:12:13Z","timestamp":1047499933000},"page":"533-538","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Increased Frequency of Cells Secreting Interleukin\u20106 and Interleukin\u201010 in Peripheral Blood of Patients with Primary Sj\u00f6gren's Syndrome"],"prefix":"10.1111","volume":"49","author":[{"family":"Halse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Tengn\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Wahren\u2010Herlenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Haga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,1,5]]},"container-title":["Scandinavian Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-3083.1999.00533.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-3083.1999.00533.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T12:44:25Z","timestamp":1698497065000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-3083.1999.00533.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["10.1046\/j.1365-3083.1999.00533.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-3083.1999.00533.x","archive":["Portico"],"relation":{},"ISSN":["0300-9475","1365-3083"],"issn-type":[{"value":"0300-9475","type":"print"},{"value":"1365-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,5]]},"assertion":[{"value":"2002-01-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}